Can Equitable Access To Monoclonal Antibody Therapies In LMICs Ever Be Attained? This Group Believes So... And So Do We
Regulatory Approach To Biosimilars In Africa
Novel Approaches To Enable Equitable Access To Monoclonal Antibodies In Low- And Middle-Income Countries
Scientific Justification And Policy Recommendations To The US Food And Drug Administration For Waiving Comparative Efficacy Studies
